Español
Nederlands
Italiano
Deutsch
Français
Português
A payment of 1,24 dollars per share in dividends from Johnson & Johnson is scheduled for March 4, 2025.
Remember, investors in Johnson & Johnson (JNJ): February 17, 2025 is your last chance to buy and qualify for dividends, keeping in mind that the Record Date is February 18, 2025, when your ownership is verified.
A dividend of 1.24 dollars was awarded by Johnson & Johnson on December 10, 2024, having a yield of 0.00%.
Jhonson & Jhonson is a mature and stable company, although its shares do not keep growing, nevertheless, it is a favorite among investors for its reliability; its dividend yield is close to 2.9%.
These payments have been made for the past 60 years in a steady and increasing manner, in fact, the board of directors announced a 5.3% increase over the previous quarter.
The corporation's dividend payment schedule is quarterly and is made in March, June, September and December.
Join +33,000 investors who get notifications, analysis and news.
Payout Ratio Johnson & Johnson Dividends
Dividend calendar of Johnson & Johnson
These are the most important events of the Johnson & Johnson calendar in 2025:
| Event | Day |
|---|---|
| Last trading date | February 17, 2025 |
| Ex-Dividend (Ex-Date) | February 18, 2025 |
| Record date | February 18, 2025 |
| Date of payment | March 4, 2025 |
Information about Johnson & Johnson
Jhonson & Johnson is an American multinational company engaged in the development, manufacture and marketing of pharmaceuticals, perfumes, personal hygiene and baby care products. It was founded in 1886 by brothers Robert Wood Johnson I, James Wood Johnson and their cousin Edward Mead Johnson.
Its main headquarters is located in New Jersey, although it is made up of more than 200 subsidiaries distributed in 57 countries, creating products that are marketed in approximately 160 nations.
In 2018, it was compromised in a lawsuit, due to the possibility that its talcum powder caused ovarian cancer, for which it had to pay more than 4 million dollars in damages, since a study revealed that this product contained carcinogenic minerals such as asbestos.
However, this did not affect its position as one of the first companies worldwide, in fact, in response to the emergency caused by Covid, they increased the manufacture of Tylenol (paracetamol) and respiratory ventilators, and also created a vaccine to combat the virus, although its reliability was compromised because in some cases it caused side effects, so in 2021 the European Union decided not to renew the contract.
Frequently asked questions about Johnson & Johnson dividends
Johnson & Johnson is listed on the New York Stock Exchange and is part of the Nyse.
Johnson & Johnson has the Ticker or stock code JNJ.
The CEO of Johnson & Johnson in 2025 is Mr. Joaquin Duato.